Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs

Advanced Drug Delivery Reviews

Volumn 56, Issue 9, 2004, Pages 1273-1289

  Lukyanov, Anatoly N ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Amphiphilic polymers; Anticancer antibody; Anticancer drugs; Enhanced permeability and retention effect; Immunomicelles; Micelles; Polymer lipid conjugates; Poorly soluble drugs; Solubilization; Tumor drug delivery

Indexed keywords

ANTIBODIES; DERIVATIVES; IMMUNOLOGY; LIPIDS; MECHANICAL PERMEABILITY; MICELLES; POLYETHYLENE GLYCOLS; SOLUBILITY;

DRUG CARRIERS; LIPID DERIVATIVES; WATER SOLUBLE POLYMERS;

DRUG PRODUCTS;

LONG CHAIN FATTY ACID; MACROGOL; PHOSPHOLIPID; POVIDONE;

DRUG DELIVERY SYSTEM; MEMBRANE PERMEABILITY; MICELLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOLUBILITY; SURFACE PROPERTY;

EID: 1942486331     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.12.004     Document Type: Article

References (85)

1. Kwon G.S., Kataoka K. Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 16:1995;295-309.
2. Jones M., Leroux J. Polymeric micelles - a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48:1999;101-111.
3. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release. 73:2001;137-172.
4. Shabner B.A., Collings J.M. Cancer Chemotherapy: Principles and Practice. 1990;Humana Press, Philadelphia.
5. Yokogawa K., Nakashima E., Ishizaki J., Maeda H., Nagano T., Ichimura F. Relationships in the structure-tissue distribution of basic drugs in the rabbit. Pharm. Res. 7:1990;691-696.
6. Hageluken A., Grunbaum L., Nurnberg B., Harhammer R., Schunack W., Seifert R. Lipophilic beta-adrenoceptor antagonists and local anesthetics are effective direct activators of G-proteins. Biochem. Pharmacol. 47:1994;1789-1795.
7. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods. 44:2000;235-249.
8. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:2001;3-26.
9. Teicher B.A. Anticancer Drug Delivery Guide. 1997;Humana Press, Philadelphia.
10. Yalkowsky S.H. Techniques of Solubilization of Drugs. 1981;Marcel Dekker, New York and Basel.
11. Thompson D., Chaubal M.V. Cyclodextrins (CDS) - excipients by definition, drug delivery systems by function (part I: injectable applications). Drug Deliv. Technol. 2:2000;34-38.
12. Ansel H.C., Allen L.V., Popovich N.G. Pharmaceutical Dosage Forms and Drug Delivery Systems. 1999;Kluwer, Philadelphia, Baltimore, New York, London.
13. Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes. 1998;Elsevier, New York.
14. Constantinides P.P., Lambert K.J., Tustian A.K., Schneider B., Lalji S., Ma W., Wentzel B., Kessler D., Worah D., Quay S.C. Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm. Res. 17:2000;175-182.
15. Rosen M.J. Surfactants and Interfacial Phenomena. 1989;Wiley Interscience, New York.
16. Ray R., Kibbe A.H., Rowe R., Shleskey P., Weller P. Handbook of Pharmaceutical Excipients. 2003;APhA Publications, Washington.
17. La S.B., Okano T., Kataoka K. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl l-aspartate) block copolymer micelles. J. Pharm. Sci. 85:1996;85-90.
18. Kabanov A.V., Batrakova E.V., Alakhov V.Y. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release. 82:2002;189-212.
19. Yokoyama M., Sugiyama T., Okano T., Sakurai Y., Naito M., Kataoka K. Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm. Res. 10:1993;895-899.
20. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release. 65:2000;271-284.
21. Palmer T.N., Caride V.J., Caldecourt M.A., Twickler J., Abdullah V. The mechanism of liposome accumulation in infarction. Biochim. Biophys. Acta. 797:1984;363-368.
22. Gabizon A.A. Liposome circulation time and tumor targeting: implications for cancer therapy. Adv. Drug Deliv. Rev. 16:1995;285-294.
23. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49:1989;4373-4384.
24. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3:1997;177-182.
25. Kohori F., Sakai K., Aoyagi T., Yokoyama M., Sakurai Y., Okano T. Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). J Control. Release. 55:1998;87-98.
26. Chung J.E., Yokoyama M., Aoyagi T., Sakurai Y., Okano T. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers. J. Control. Release. 53:1998;119-130.
27. Le Garrec D., Taillefer J., Van Lier J.E., Lenaerts V., Leroux J.C. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model. J. Drug Target. 10:2002;429-437.
28. Gregoriadis G. Targeting of drugs. Nature. 265:1977;407-411.
29. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237.
30. Torchilin V.P., Shtilman M.I., Trubetskoy V.S., Whiteman K.R., Milstein A.M. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim. Biophys. Acta. 1195:1994;181-184.
31. Torchilin V.P., Levchenko T.S., Whiteman K.R., Yaroslavov A.A., Tsatsakis A.M., Rizos A.K., Michailova E.V., Shtilman M.I. Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. Biomaterials. 22:2001;3035-3044.
32. Benahmed A., Ranger M., Leroux J.C. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L- lactide). Pharm. Res. 18:2001;323-328.
33. Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
34. Blume G., Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta. 1146:1993;157-168.
35. Torchilin V.P., Omelyanenko V.G., Papisov M.I., Bogdanov A.A. Jr., Trubetskoy V.S., Herron J.N., Gentry C.A. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta. 1195:1994;11-20.
36. Bedu-Addo F.K., Tang P., Xu Y., Huang L. Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: sterically stabilized liposome formulations. Pharm. Res. 13:1996;718-724.
37. Edwards K., Johnsson M., Karlsson G., Silvander M. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys. J. 73:1997;258-266.
38. Trubetskoy V.S., Torchilin V.P. Polyethyleneglycol based micelles as carriers of therapeutic and diagnostic agents. Stp Pharma Sci. 6:1996;79-86.
39. Gabizon A.A. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 19:2001;424-436.
40. Martin A. Physical Pharmacy. 1993;Lippinkott Williams and Wilkins, Philadelphia.
41. Weissig V., Lizano C., Torchilin V.P. Micellar delivery system for dequalinium - a liphophilic cationic drug with anticarcinoma activity. J. Liposome Res. 8:1998;391-400.
42. Weissig V., Whiteman K.R., Torchilin V.P. Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm. Res. 15:1998;1552-1556.
43. Torchilin V.P., Lukyanov A.N., Gao Z., Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. USA. 100:2003;6039-6044.
44. Allen C., Yu Y., Maysinger D., Eisenberg A. Polycaprolactone-b- poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconjug. Chem. 9:1998;564-572.
45. Smith R., Tanford C. The critical micelle concentration of L-dipalmitoylphosphatidylcholine in water and water-methanol solutions. J. Mol. Biol. 67:1972;75-83.
46. Lee J.H., Jung S.W., Kim I.S., Jeong Y.I., Kim Y.H., Kim S.H. Polymeric nanoparticle composed of fatty acids and poly(ethylene glycol) as a drug carrier. Int. J. Pharm. 251:2003;23-32.
47. Lukyanov A.N., Gao Z., Mazzola L., Torchilin V.P. Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm. Res. 19:2002;1424-1429.
48. Yokoyama M., Satoh A., Sakurai Y., Okano T., Matsumura Y., Kakizoe T., Kataoka K. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J. Control. Release. 55:1998;219-229.
49. Kim S.Y., Shin I.G., Lee Y.M., Cho C.S., Sung Y.K. Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviors. J. Control. Release. 51:1998;13-22.
50. Gao Z., Lukyanov A.N., Singhal A., Torchilin V.P. Diacyl-polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett. 2:2002;979-982.
51. Gao Z., Lukyanov A.N., Chakilam A.R., Torchilin V.P. PEG-PE/ phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J. Drug Target. 11:2003;87-92.
52. Krishnadas A., Rubinstein I., Onyuksel H. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm. Res. 20:2003;297-302.
53. Alkan-Onyuksel H., Ramakrishnan S., Chai H.B., Pezzuto J.M. A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm. Res. 11:1994;206-212.
54. Balasubramanian S.V., Straubinger R.M. Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. Biochemistry. 33:1994;8941-8947.
55. Wenk M.R., Fahr A., Reszka R., Seelig J. Paclitaxel partitioning into lipid bilayers. J. Pharm. Sci. 85:1996;228-231.
56. Maeda H., Sawa T., Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release. 74:2001;47-61.
57. Senior J.H. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
58. Trubetskoy V.S., Gazelle G.S., Wolf G.L., Torchilin V.P. Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography. J. Drug Target. 4:1997;381-388.
59. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., Martin F.J. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA. 88:1991;11460-11464.
60. Gabizon A.A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52:1992;891-896.
61. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA. 95:1998;4607-4612.
62. Kabanov A.V., Chekhonin V.P., Alakhov V., Batrakova E.V., Lebedev A.S., Melik-Nubarov N.S., Arzhakov S.A., Levashov A.V., Morozov G.V., Severin E.S., Kabanov V.A. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett. 258:1989;343-345.
63. Yokoyama M., Okano T., Sakurai Y., Kataoka K., Inoue S. Stabilization of disulfide linkage in drug-polymer-immunoglobulin conjugate by microenvironmental control. Biochem. Biophys. Res. Commun. 164:1989;1234-1239.
64. Vinogradov S., Batrakova E., Li S., Kabanov A. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjug. Chem. 10:1999;851-860.
65. Chekhonin V.P., Kabanov A.V., Zhirkov Y.A., Morozov G.V. Fatty acid acylated Fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain. FEBS Lett. 287:1991;149-152.
66. Nagasaki Y., Yasugi K., Yamamoto Y., Harada A., Kataoka K. Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules. Biomacromolecules. 2:2001;1067-1070.
67. Jule E., Nagasaki Y., Kataoka K. Lactose-installed poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles exhibit fast-rate binding and high affinity toward a protein bed simulating a cell surface. A surface plasmon resonance study. Bioconjug. Chem. 14:2003;177-186.
68. Lee E.S., Na K., Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J. Control. Release. 91:2003;103-113.
69. Iakoubov L.Z., Torchilin V.P. A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice. Oncol. Res. 9:1997;439-446.
70. Iakoubov L.Z., Rokhlin O., Torchilin V.P. Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Immunol. Lett. 47:1995;147-149.
71. Torchilin V.P., Levchenko T.S., Lukyanov A.N., Khaw B.A., Klibanov A.L., Rammohan R., Samokhin G.P., Whiteman K.R. p-Nitrophenylcarbonyl-PEG-PE- liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim. Biophys. Acta. 1511:2001;397-411.
72. Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA. 98:2001;8786-8791.
73. Lukyanov A.N., Gao Z., Torchilin V.P. Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. J. Control. Release. 91:2003;97-102.
74. Park J.W., Kirpotin D.B., Hong K., Shalaby R., Shao Y., Nielsen U.B., Marks J.D., Papahadjopoulos D., Benz C.C. Tumor targeting using anti-her2 immunoliposomes. J. Control. Release. 74:2001;95-113.
75. Abuchowski A., van Es T., Palczuk N.C., McCoy J.R., Davis F.F. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L- asparaginase. Cancer Treat. Rep. 63:1979;1127-1132.
76. Harris J.M., Martin N.E., Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin. Pharmacokinet. 40:2001;539-551.
77. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54:2002;459-476.
78. Veronese F.M., Harris J.M. Introduction and overview of peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54:2002;453-456.
79. Lasic D.D., Martin F. Stealth Liposomes. 1995;CRC Press, Boca Raton.
80. Calvo P., Gouritin B., Brigger I., Lasmezas C., Deslys J., Williams A., Andreux J.P., Dormont D., Couvreur P. PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases. J. Neurosci. Methods. 111:2001;151-155.
81. Moghimi S.M. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Biochim. Biophys. Acta. 1590:2002;131-139.
82. Johnson S.D., Anderson J.M., Marchant R.E. Biocompatibility studies on plasma polymerized interface materials encompassing both hydrophobic and hydrophilic surfaces. J. Biomed. Mater. Res. 26:1992;915-935.
83. Sharma D., Chelvi T.P., Kaur J., Chakravorty K., De T.K., Maitra A., Ralhan R. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle- encapsulated Taxol for drug delivery in cancer therapy. Oncol. Res. 8:1996;281-286.
84. Moneghini M., Voinovich D., Princivalle F., Magarotto L. Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with carbamazepine. Pharm. Dev. Technol. 5:2000;347-353.
85. Luppi B., Orienti I., Bigucci F., Cerchiara T., Zuccari G., Fazzi S., Zecchi V. Poly(vinylalcohol-co-vinyloleate) for the preparation of micelles enhancing retinyl palmitate transcutaneous permeation. Drug Deliv. 9:2002;147-152.